Compounds having both potent calcium antagonist and antioxidant

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514255, 514292, 514317, 514320, 514323, 514324, 514331, 544361, 544372, 544376, 544377, 544396, 546 86, 546192, 546197, 546200, 546202, 546230, 546240, A61K 31495, A61K 31445, C07D40506, C07D41106

Patent

active

056461496

ABSTRACT:
Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.

REFERENCES:
patent: 3868377 (1975-02-01), Raabe et al.
patent: 4550022 (1985-10-01), Garabedian et al.
patent: 5015661 (1991-05-01), Walser
patent: 5120843 (1992-06-01), McCall et al.
Peruche, et al., "Mechanisms of Drug Actions Against Neuronal Damage Caused by Ischemia--An Overview", Prog. Neuro-Psychophamacol. and Biol. Psychiat., vol. 17, pp. 21-70 (1993).
Miller, R., "Multiple Calcium Channels and Neuronal Function", Science, vol. 235, pp. 46-52 (1987).
Barrett, R., et al., "AHR-16303B, a Novel Antagonist of 5-HT.sub.2 Receptors and Voltage-Sensitive Calcium Channels", Journal of Cardiovascular Pharmacology, vol. 17, No. 1, pp. 41-53 (1991).
Sahly, et al., "Calcium channel blockers inhibit retinal degeneration in the retinal-degeneration-B mutant of Drosophila", Proc. Natl. Acad. Sci. USA, vol. 89, pp. 435-439 (1992).
Beck, et al., "Local cerebal glucose utilization and local ceberal blood flow in conscious rats after administration of flunarizine", Naunyn-Schmiedeberg's Arch Pharmacol., vol. 335, pp. 680-685 (1987).
Aruoma, et al., "Free Radical Scavenging And Inhibition Of Lipid Peroxidation By .beta.-Blockers And By Agents That Interfere With Calcium Metabolism", Biochemical Pharmacology, vol. 42(4), pp. 735-743 (1991).
Orrenius, et al., "Calcium Ions and Oxidative Cell Injury", Annals of Neurology, supplement to vol. 32, pp. .sctn.33-42 (1992).
Jackson, et al., "Antioxidants: A Biological Defense Mechanism for the Prevention of Atherosclerosis", Medicinal Research Reviews, vol. 13, No. 2, pp. 162-182 (1993).
Li, et al., "Amelioration of Retinal Photic Injury by a Combination of Flunarizine and Dimethylthiourea", Experimental Eye Research, vol. 56, pp. 71-78 (1993).
Kubo, et al., "Radical Scavenging Action of Flunarizine in Rat Brain in vitro", Arch. int. Pharmacodyn., vol. 272, pp. 283-295 (1984).
Mak, et al., "Comparative Antioxidant Activities of Propranolol, Nifedipine, Verapamil, and Diltiazem Against Sarcolemmal Membrane Lipid Peroxidation", Circulation Research, vol. 66, No. 5, pp. 1449-1452 (1990).
Breugnot, C., et al., "Calcium Antagonists Prevent Monocyte and Endothelial Cell-Induced Modification Of Low Density Lipoproteins", Free Rad. Res. Comms., vol. 15, No. 2, pp. 91-100 (1991).
Zimmerman, J., et al., "In Vitro Modulation of Human Neutrophil Superoxid Anion Generation By Various Calcium Channel Antagonists Used in Ischemia-Reperfusion Resuscation", Biochemical Pharacology, vol. 38, No. 20, pp. 3601-3610 (1989).
Ehlert, F., et al., "The Binding of [.sup.3 H]Nitrendpine To Receptors for Calcium Channel Antagonists in the Heart, Cerebral Cortex, and Ileum of Rats", Life Science, vol. 30, pp. 2191-2202 (1982).
Lamba, O., et al., "Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system", Biochimieu et Biophysica Act., 1081, pp. 181-187 (1991).
Gould, R., et al., "[.sup.3 H]Nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists", Proc. Natl. Acad. Sci. USA, vol. 79, pp 3656-3660 (1982).
Scheschonka, A., et al., "Temporal Relationships Between The Loss of Vitamin E, Protein Sulfhydryls and Lipid Peroxidation in Microsomes Challenged With Different Prooxidants", Chem.-Biol. Interactions, vol. 74, pp. 233-252 (1990).
Shanklin Jr., J.. et al., "Synthesis, Calcium-Channel-Blocking Activity, and Antihypertensive Activity 4-(Diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and Structurally Related Compounds", Journal of Medicinal Chemistry, vol. 34, No. 10, 3011-3022 (1991).
Eziri et al., Chemical Abstracts, vol. 109, No. 22844 (1988) (Abstract fo WO 87/05020, Aug. 27, 1987)..
Aono et al., Chemical Abstracts, vol. 117, No. 90125 (1992) (Abstract for EP 483772, May 6, 1992).
Drug Evaluations by American Medical Association (1993) pp. 2105-2106.
Silver et al., "Low Molecular Weight Analogs of Trolox with Potent Activity In Vitro and In Vivo," Drug Development Research, 27:45 (1992).
Rice-Evans et al., "Current Status of Antioxidant Therapy", Free Radical Biology and Medicine, 15:77 (1993).
Janero et al., "Protection of Cardiac Membrane Phospholipid Against Oxidative Injury by Calcium Antagonists", Biochem. Pharm., 37(21):4197 (1989).
Scott et al., "6-hydroxychroman-2-carboxylic Acids: Novel Antioxidants", JAOCS, 51:200 (1974).
Van Acker et al., "Molecular Pharmacology of Vitamin E: Structural Aspects of Antioxidant Activity", Free Radical Biology and Medicine, 15:311(1993).
Petty et al., "Protective Effects of an .beta.-Tocopherol Analogue Against Myocardial Reperfusion Injury in Rats", E. J. Pharm., 210:85 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds having both potent calcium antagonist and antioxidant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds having both potent calcium antagonist and antioxidant , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having both potent calcium antagonist and antioxidant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2408985

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.